We have identified a new immunoglobulin heavy-chain enhancer element, designated x, between the LE2 and ,E3 elements. The -w enhancer element is transcriptionally active primarily during early stages of B-cell development but becomes virtually inactive during B-cell maturation at about the stage of immunoglobulin K light-chain gene rearrangement. Mutational analysis suggests that the wr element is crucial for immunoglobulin heavy-chain enhancer activity at the pre-B-cell stage but is almost irrelevant for enhancer activity at the mature B-cell or plasma-cell stage. The activity ofthe w enhancer element correlates with the presence of an apparently pre-B-cell-specific protein-DNA complex. The similarity of the wr site to recognition sequences for members of the ets gene family suggests that the protein(s) interacting with the w site most likely are as-related transcription factors.
been shown to be of utmost importance for both B-cellspecific and developmental-stage-specific expression of the IgH gene as well as for the recombinational process (17, 42) . Additional enhancers 3' of the IgH gene have been identified but have not been characterized in more detail (13, 45) .
A 700-bp XbaI-EcoRI fragment (±700) contains most of the activity of the intronic IgH enhancer and functions during all stages of B-cell development but is inactive in nonlymphoid cells (39) . The IgH enhancer shows a complex modular arrangement of several different overlapping stimulatory and negative elements (see Fig. 1 ) (21, 39, 42) . The B-cell specificity of the IgH enhancer is apparently regulated by positively acting B-cell-specific enhancer elements, including octamer and 3B, negatively acting non-B-cell-specific silencer elements, and protein-protein interactions between these B-cell-specific factors and ubiquitously expressed transcription factors (4, 5, 11, 20, 31, 33, 39, 42, 44, 52, 55, 65, 73) .
We have characterized the B-cell-specific enhancer element, ,uB, in more detail and have shown that the pB element is a critical component of the IgH enhancer in lymphoid cell-specific expression (44, 52) . Both the octamer and the pB elements are active during all stages of B-cell development, correlating with the transcriptional activity of IgH genes (39, 44, 52) , even though the octamer element appears to be less active at the pre-B-cell stage. We now report the identification of a novel enhancer element, designated Tr, between the ,E2 and ,uE3 elements of the IgH enhancer (see Fig. 1 ). We show that this highly conserved enhancer element is pre-B-cell specific and of crucial importance for the activity of the IgH enhancer at the pre-B-cell stage only. The similarity of the Tr site to binding sites for members of the ets gene family suggests that the protein(s) interacting with the 7r site belong to the ets gene family. ously (6, 7) . Samples of 20 pl containing 5 p,g of nuclear extract, 0.5 ,ug of heparin-agarose-purified nuclear factors, or 4 RI of affinity-purified nuclear factor ir were incubated with 0.1 to 0.2 ng of a 32P-labeled immunoglobulin (Ig) vr wild-type DNA fragment (5,000 cpm)-10 mM Tris-Cl (pH 7.5)-50 mM NaCl-1 mM dithiothreitol (DlT)-1 mM EDTA-1.75% polyvinyl alcohol-5% glycerol-2 ,ug of bovine serum albumin (Boehringer) and with 2 ,ug of poly(dI-dC), 1 F±g of poly(dI-dC), or 0.4 pug of poly(dI-dC) for total nuclear extract, heparin-agarose-purified nuclear factors, or affinitypurified nuclear factors, respectively. Samples were incubated in the presence or absence of competitor oligonucleotides for 15 min at room temperature and run on 4% polyacrylamide gels containing as a buffer 25 mM Tris-HCl (pH 8.5), 190 mM glycine, and 1 mM EDTA.
Oligonucleotides used for competition studies were as follows: V ,r, A PRE-B-CELL ENHANCER 5'-TCGACTGGCAGGAAGCAGGTCATGC-3' 3'-GACCGTCCTTCGTCCAGTACGAGCT-5' containing Sall and XhoI ends was inserted as a monomer, a trimer, and a nonamer into the SalI site of the A56-c-fos-CAT plasmid (22, 39) . Similarly, trimers of mutant oligonucleotides Ig ir Ml, Ig ur M2, and Ig r M3 (see above) were inserted into the SalI site in the A56-c-fos-CAT plasmid.
Site-directed mutagenesis. Specific site-directed mutagenesis of four nucleotides in the ir DNA motif of the murine IgH enhancer were introduced by the gap-heteroduplex method (66) with oligonucleotide 5'-CTGCAGCAGCTGG CCTCGAGCAGGTCATGTGG-3' (see Fig. 6b ). Mutant IgH enhancer constructs were partially sequenced. At least two independent isolates of each mutant construct were grown, analyzed, and used for the experiments.
DNA transfection assays. Cells were transfected with 10 ,ug of DNA by the DEAE-dextran method (39, 56) , except that C127 cells were transfected by the calcium phosphate coprecipitation method (39, 57 cell extract was assayed for CAT activity as described previously (24) in a 1-or 2-h incubation at 37°C. Transfections for every construct were performed independently in duplicate and repeated two to four times. Samples were analyzed by thin-layer chromatography (24) . The percentage of acetylated chloramphenicol was determined by cutting out samples of nonacetylated and acetylated forms of chloramphenicol and measuring the amount of radioactivity by liquid scintillation counting.
RESULTS
Identification of a novel enhancer element, w, in the IgH enhancer. While analyzing the murine IgH enhancer by DNase footprinting for protein-DNA interactions, we recently (44) observed between the pLE2 and ,uE3 enhancer elements a putative lymphoid cell-specific footprint that had not been previously described (Fig. 1) . The sequence of this putative enhancer element, 5'-CAGGAAGCAGGT-3', is depicted in Fig. lb , and we refer to this site as the ir site.
To determine whether the site indeed acts as an enhancer element, we generated a synthetic 25-bp oligonucleotide containing the ir DNA motif ( Fig. 1 ) (see Materials and Methods). We inserted one, three, or nine copies of this oligonucleotide upstream of the truncated c-fos promoter in the A56 plasmid (22) . Enhancer activity was measured as the ability of the different constructs to induce transcription of the CAT gene after transient expression in the murine pre-B-cell line BASC 6C2 (30, 56 Fig. 11 and 12), are indicated above the DNA sequences. The putative binding site for pre-B-cell-specific activity is indicated by the shaded box.
ities of these constructs were compared with that of the parental enhancerless A56 plasmid itself. pSV2CAT, which contains the simian virus 40 (SV40) enhancer (24) , served as a positive control and was very active in BASC 6C2 cells. As shown in Fig. 2 , very little CAT activity was detectable with the A56 plasmid itself, whereas one copy of the rr element stimulated transcription almost 10-fold. Enhancer activity increased with increased copy number, such that nine copies of the Fr element stimulated transcription by more than 400-fold. These results indicate that the r site is a very powerful enhancing element.
The wr enhancer element is active only in pre-B cells. To determine whether the r enhancer element is regulated during B-cell development, we transfected murine cell lines representing different stages of B-cell development with the A56 plasmid containing one, three, or nine copies of the enhancer element or containing three copies of another, lymphoid cell-specific IgH enhancer element, ,B (44). pSV2CAT, ,u300 (the region between the PvuII and EcoRI sites shown in Fig. 1 ), and R700 (the region between the XbaI and EcoRI sites shown in Fig. 1 ) (39) served as positive controls. The SV40 enhancer and IgH enhancer fragments ,u300 and ,u700 (data not shown) stimulated transcription in all cell lines. However, the 'rr enhancer element was active only in pre-B-cell lines HAFTL, PD31, and BASC 6C2 and virtually inactive in mature B-cell line WEHI 231 or myeloma cell line S194 (Fig. 3) . Only with nine copies of the rr enhancer element was some activity detected in the myeloma cell line, but no activity was seen in the mature B-cell line. Three copies of the ,uB enhancer, in contrast, did not express any intrinsic enhancer activity in any cell line.
To test in more detail the stage and tissue specificity of the A. 'Fr enhancer element, we transfected a wider range of cell lines with the A56 plasmid containing three copies of the 'r enhancer element and compared its activity in these cell lines with that of the parental A56 plasmid. Again, the enhancer element was a potent enhancer only in pre-B-cell lines, increasing transcription 14-to 36-fold, depending on the cell line (Fig. 4) . Practically no enhancer activity was detected in late pre-B, mature B, or myeloma cells. Furthermore, the Tr enhancer element was also inactive in Jurkat T cells, U-937 monocytic cells, and C127 mammary cells. These results suggest that the IgH enhancer contains in addition to the lymphoid cell-specific enhancer elements ,uB and octamer, which are active during all stages of B-cell development, a stage-specific enhancer element, Tr.
Effect of mutations on the activity of an isolated 'rr enhancer element. To further define the sequence requirements for 'r enhancer activity, we synthesized several oligonucleotides (Ml, M2, and M3) that spanned the rr element and that contained mutations of either two or three nucleotides in the 'rr site (Fig. 5) . Three copies of these mutant oligonucleotides were inserted into the A56 plasmid. The transcriptional activities of mutant 'r enhancers were compared with those of the wild-type 'r enhancer trimer and the parental A56 plasmid (Fig. 5) . The mutation in Ml, in the 5' half of the vr site, almost completely abrogated all enhancer activity (Fig.  5) . The mutation in M2 reduced the enhancer activity of the zr element only slightly, and the mutation in M3, at the 3' end of the r site, had no effect on transcriptional activity (Fig. 5) . These data suggest that the 5' half of the 7r site contains most, if not all, of the sequence required for enhancer activity.
Mutation of the 'rr site reduces the activity of the IgH enhancer specifically in pre-B cells. To test whether the rr enhancer element contributes to the activity of the IgH enhancer in the context of the whole 700-bp enhancer, we introduced a mutation affecting the same region of 'r as the Ml mutation, which inhibits the function of an isolated rr element, into the rr site of p700 (Fig. 6b) . The full-length 700-bp wild-type (,700 WT) and mutant (,u00 '-) IgH enhancers, cloned into the A56 plasmid (22) , were transiently expressed in B-cell lines of different developmental stages, and the transcriptional activity of the mutant enhancer was compared with that of the wild-type enhancer. Mutation of the rr site within R700 drastically reduced the activity of the IgH enhancer in the pre-B-cell lines HAFTL and PD31 ( Fig. 6a ) but had only a slight effect in the mature B-cell line WEHI 231 or in the myeloma cell lines S194 and X63 Ag8. CAT activity was reduced by -65% in PD31 and by more than 80% in HAFTL pre-B cells but at most 20% in mature B or myeloma cells (Fig. 6a) . These data most vividly illustrate the pre-B-cell specificity of the 'r enhancer element and strongly suggest that the 'r site is an important element for transcriptional control of the IgH enhancer at the pre-B-cell stage but not during later stages of B-cell development. Mutation of the Tr site inhibits the binding of a nuclear factor to the IgH enhancer. To correlate the functional data described above with the binding of a specific protein to the 'rr site and to confirm that mutation of the 'r site decreases the binding of a specific nuclear factor, we carried out DNase I footprinting experiments with the noncoding strand of the ,u700 WT or ,u00 'r-IgH enhancer. We compared a Hinfl-DdeI fragment of p700 WT with that of ,700 ir-by using a nuclear extract derived from the pre-B-cell line HAFFL. Proteins bound to ,uE2, p,E3, ,uE5, and ,uB were detected in both wild-type and mutant enhancers (Fig. 7A  and B) . The HAFTL extract gave rise to a strong footprint over the wild-type ir site (Fig. 7A and C) . In contrast, no footprint was seen over the functionally important 5' half of the mutant Tr site (Fig. 7B and C) . Interestingly, a footprint over the functionally inactive 3' half of the mutant Fr site was VOL. 13, 1993 still present (Fig. 7B) , suggesting the presence of two separate binding sites for two different factors in the 7r site (Fig.  7C) . Similar results were obtained with the coding strand (data not shown). Apparent protein-DNA interactions over the Tr site, based on the results of these DNase I footprinting assays and EMSA (see Fig. 11 and 12) are shown in Fig. 7C . Our results confirm that mutation of the Tr site indeed decreases the affinity for a specific Tr-binding factor and also To determine whether a pre-B-cell-specific protein binds to the r site, we performed DNase I footprinting experiments with the noncoding (Fig. 8 ) and coding (data not shown) strands of the ,u700 IgH enhancer. We compared nuclear extracts derived from several different cell types of both lymphoid and nonlymphoid origins. Proteins bound to ,uE1, ,uE2, ,uE3, and E were detected in extracts of most cell types (Fig. 8) . A strong footprint over the ,uB DNA motif was seen in extracts from B and T cells, as well as myeloid cells, but was absent in extracts from nonhematopoietic glioma, fibroblastic, bladder carcinoma, and mammary cells (Fig. 8) . Protein-DNA interactions over the r site appeared to be more complex. A footprint over the ir DNA motif was detected in every nuclear extract (Fig. 8) 15) . complex might be relevant for the activity of the r site and, like the DNase I footprinting experiments, these experiments suggested that nuclear extracts from a variety of different cell types contain proteins that have similar or identical binding specificities for the vr site in vitro.
To characterize further the proteins interacting with the 'r enhancer element, we fractionated nuclear extracts over heparin-Sepharose (Fig. 10) . We performed EMSA with heparin-Sepharose-purified nuclear proteins from pre-B-cell lines BASC 6C2 and HAFTL, mature B-cell line WEHI 231, glioma cell line U-1240 Mg, and cervical carcinoma cell line HeLa (Fig. 11) . As shown in Fig. 11 , complex 1 appeared to be present in extracts from the two pre-B-cell lines but not in extracts from mature B, glioma, or cervical carcinoma cells. We refer to complex 1 as NF-mr. Complexes 2 and 3 were present in both pre-B and mature B cells but not in glioma or cervical carcinoma cells. Complexes 10 and 11 were formed only by proteins present in glioma and cervical carcinoma cells.
These results indicate that a variety of different tissuerestricted proteins interact with the Fr enhancer element. The data also suggest that NF-r may be a pre-B-cell-specific nuclear factor that correlates with the pre-B-cell-specific activity of the ir enhancer element, although additional experiments will be needed to prove this suggestion.
Further purification of ir-binding factors was achieved by affinity chromatography of a heparin-Sepharose-fractionated nuclear extract from the pre-B-cell line HAFTL over a 'r oligonucleotide-Sepharose column. Complexes 1 to 4 were the major proteins eluting from the ir-Sepharose column (Fig. 10) . Complexes 1 and 2 were the major components of the 200 and 300 mM KCl eluates.
Mutations affecting the activity of the ii enhancer element inhibit the binding of pre-B-cell-specific nuclear factor NF-Wr.
To test whether the presence of the pre-B-cell-specific factor NF-'Tr (complex 1) correlates with the function of the vr VOL. 13, 1993 enhancer element and to analyze the sequence requirements for the binding of the different nuclear factors to the site, we tested the specificity of binding in competition experiments. The wild-type wr oligonucleotide as well as the mutant 'rr oligonucleotides Ml, M2, and M3 (Fig. 5) were used as competitors in EMSA with the oligonucleotide-Sepharose affinity-purified 200 mM KCl eluate from HAFIL cells and the wild-type ir oligonucleotide as a probe (Fig. 12) . The wild-type oligonucleotide competed effectively with complexes 1 (NF-'rr), 2, and 3 for binding (Fig. 12, lanes 2 to 4) . (Fig. 12, lanes 11 to  13 ). These data demonstrate that mutations of the rr enhancer element that abrogate its activity (Fig. 5 ) also eliminate the binding of NF-'rr ( Fig. 12 ) but have no effect or only a marginal effect on the formation of complexes 2 and 3. On the other hand, mutations that have no effect on r enhancer activity have no effect on the binding of NF-'r but result in a significant reduction in the formation of complexes 2 and 3. These findings confirm that binding specificity and the presence of NF-ir strictly correlate with the activity of the enhancer element in pre-B cells. On the basis of these results, together with the DNase I footprinting results, we can conclude that NF-'r binds to the 5' part of the 'rr site, to the minimal sequence GCAGGAAGC. Complexes 2 and 3 appear to interact with the 3' part of the ir site but have very little effect on the activity of the Tr enhancer element.
The enhancer element is conserved through the evolution of the IgH gene. The importance of particular enhancer elements for the transcriptional regulation of a gene is often reflected in their conservation through evolution. When we compared the DNA sequences of the murine, human, and rat IgH enhancers (10, 15, 49) , the only ones available, it was evident that the Fr enhancer element is 100% conserved, whereas other enhancer elements, including ,uB, ,uE2, and ,uE3, contain several nucleotide differences (Fig. 13) . This result suggests that the r enhancer element may be of crucial importance for the proper regulation of IgH gene expression.
Regulatory regions of several B-cell-specific genes contain sr-like DNA motifs. To examine the possibility that other B-cell-specific genes are regulated through rr-like enhancers, we analyzed the promoter and enhancer regions of a variety of lymphoid cell-specific genes for the presence of Tr-like DNA motifs. We observed rr-like DNA motifs in several B-cell-specific genes, including v-preB (36), X5 (37), TdT (61) , and B29 (27) ( Table 1 ), suggesting that NF-Fr may be involved in the control of a whole set of B-cell-specific genes. In addition, both the proximal and the distal promoters of the T-cell-specific Ick gene (19, 67) contain a highly homologous DNA motif that is 100% conserved. This fact suggests that a T-cell-specific NF-rr-related protein may be involved in T-cell-specific gene expression. Purified NF-'r protein will enable us to determine whether these related DNA motifs bind NF-Tr as well.
Their enhancer element shows a high degree of similarity to binding sites for members of the ets transcription factoroncogene family. To determine whether previously described transcription factors interact with the 'r enhancer element, we compared the NF-'r-binding site with DNA motifs recognized by known transcription factors. We observed a striking homology between the DNA-binding sites for members of the ets gene family (48, 53, 64, 70) and that for NF-rr, especially in the core GGAA motif (Table 2 ). In particular, binding sites for PEA3 (71, 74) and Ets-1 and Ets-2 (23, 25, 29, 40, 53, 72) are remarkably similar to those for NF-rr. Furthermore, the ,uB site of the IgH enhancer, which is located downstream of iTr, contains a similar GGAA motif, and we recently found that the Pu.1 transcription factor (35), a member of the ets family, binds specifically to the ,uB site and that its binding pattern correlates with the functional activity of this site (1). We are now in the process of evaluating the interaction of several members of the ets (48, 54, 64) . Because transcription of the unrearranged IgH gene occurs prior to rearrangement and appears to be essential for recombination (9, 62, 63) , the 'r element might be a critical activator of IgH sterile transcription as well. A variety of other B-cell-specific genes contain DNA motifs similar to 'r; thus, NF-7r might be an important regulatory factor in the control of B-cellspecific gene expression and B-cell differentiation.
The 'r site represents a novel pre-B-cell-specific regulatory element in the IgH enhancer. Its similarity to binding sites for ets-related transcription factors suggests that a member of the ets gene family might interact with the 7r site. Indeed, the IgH enhancer contains another ets-related enhancer element, ,uB (42, 44, 52) , with the typical 5'-GGAA-3' sequence of ets-related binding sites (48, 53) occurring at its center. We (1) have shown that pB binds a B-cell-or macrophage-specific member of the ets family, Pu.1 (35) . Pu.1 appears, however, not to interact with 'Fr (1) . There are several other striking differences between the 'r site and the p,B site, making it unlikely that the same factors interact with both sites. Whereas ,B is active throughout B-cell development (44, 52) , 'r appears to act primarily at the pre-B-cell stage. Furthermore, an isolated r site, but not an isolated ,uB site, functions as an autonomous enhancer. In addition, gel mobility shift assays for 'r and ,tB have revealed different protein-DNA complexes and a distinct cell type distribution (1) . Therefore, we can assume that the IgH enhancer contains at least two distinct ets-related enhancer elements with strikingly different activities. This feature is very similar to those of a whole set of T-cell-specific genes, including the interleukin-2, alpha and beta T-cell receptor, CD2, and CD3 genes, all of which have at least two critical ets-related enhancer elements (29, 68, 70) . Several other B-cell-specific genes, including the Ig K, TdT, and mb-i genes, apparently also contain ets-related binding sites in their regulatory regions (16, 26, 46, 58) . We and others have shown elsewhere that ,uB is important for the B-cell-specific activity of the IgH enhancer (44, 52) , and we now show the crucial role of the 'rr site for the activity of the IgH enhancer at the pre-B-cell stage. Therefore, it is likely that ets-related transcription factors play similar crucial roles in B-cell-specific gene regulation and potentially B-cell differentiation, as has been proposed for T cells.
We do not know the identity of NF-'r yet. However, in an attempt to isolate members of the ets gene family that are expressed in pre-B cells, we recently cloned and characterized the gene for a novel ets-related transcription factor, ERP (for Ets-related protein) (47) . The expression of the ERP factor in the B-cell lineage appears to be elevated at the pre-B-cell stage and to decline upon B-cell maturation. We are now in the process of determining whether ERP is able to interact with the 'r site. Several other ets-related enhancer elements, including LyF-1 and BLyF, have been identified for other B-cellspecific genes with binding sites similar to Fr (16, 46) . On the basis of the activities and expression patterns of LyF-1 and BLyF, NF-i seems to be distinct from these factors.
We have noted the presence of 7r-related DNA sequences in at least three pre-B-cell-specific genes, the TdT (61), v-preB (36) , and X5 (33) genes. We have no evidence as to their function or whether they interact with NF-'r. Nevertheless, the presence of potential Ir sites in other genes expressed at the pre-B-cell stage enhances the possibility that NF-IT plays an important role in early B-cell gene regulation and B-cell differentiation. VOL. 13, 1993 
